本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

188.44
-5.5100-2.84%
盘后:190.051.61+0.85%19:30 EDT
成交量:294.18万
成交额:5.58亿
市值:403.90亿
市盈率:-21.12
高:193.61
开:191.57
低:187.14
收:193.95
52周最高:224.31
52周最低:47.45
股本:2.14亿
流通股本:1.85亿
量比:1.27
换手率:1.59%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
净资产收益率:-79.09%
总资产收益率:-30.12%
市净率:15.50
市盈率(LYR):-31.67

数据加载中...

2023/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/11/01

重要事件披露

Form 8-K - Current report
2023/10/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/10/23

重要事件披露

Form 8-K - Current report
2023/10/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/13

重要事件披露

Form 8-K - Current report
2023/10/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/28

SEC问询函

Form CORRESP - Correspondence
2023/09/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/05

重要事件披露

Form 8-K - Current report
2023/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities